[HTML][HTML] Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis
N Roehlen, F Stoehr, L Müller… - Hepatology …, 2023 - journals.lww.com
Background: Postembolization syndrome (PES) represents the most frequent complication
after transarterial chemoembolization (TACE) in patients with HCC. Given the vague …
after transarterial chemoembolization (TACE) in patients with HCC. Given the vague …
Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization
JJ He, XX Yin, T Wang, MY Chen, XL Li… - Journal of Cancer …, 2021 - journals.lww.com
Aims: We explored the factors influencing PES in patients with HCC undergoing TACE for
the first time. Settings and Design: The present study was a hospital-based study conducted …
the first time. Settings and Design: The present study was a hospital-based study conducted …
Risk factors for postembolization syndrome after transcatheter arterial chemoembolization
M Arslan, S Degirmencioglu - Current Medical Imaging, 2019 - ingentaconnect.com
Background: Transarterial Chemoembolization (TACE) is a minimally invasive treatment in
managing unresectable liver primary neoplasms or liver metastases. Postembolization …
managing unresectable liver primary neoplasms or liver metastases. Postembolization …
Clinical features and treatment of hepatic abscesses with biloma formation after transcatheter arterial chemoembolization
M Zhu, G Li, Y Chen, G Gong, W Guo - Arab Journal of Gastroenterology, 2022 - Elsevier
Background and study aims A full understanding of the clinical manifestations and risk
factors for hepatic abscesses with biloma formation after transcatheter arterial …
factors for hepatic abscesses with biloma formation after transcatheter arterial …
Clinical research progress of callisperes® of drug-loaded microsphere arterial chemoembolisation in the treatment of solid tumors
Q Wang, L Zhu, Q Sheng - Discover Oncology, 2024 - Springer
The incidence and mortality of cancer is ever-increasing, which poses a significant
challengesto human health and a substantial economic burden to patients. At present …
challengesto human health and a substantial economic burden to patients. At present …
[HTML][HTML] Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer
LF Bian, XH Zhao, BL Gao, S Zhang… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Transarterial chemoembolization (TACE) is the first-line treatment for
patients with unresectable liver cancer; however, TACE is associated with postembolization …
patients with unresectable liver cancer; however, TACE is associated with postembolization …
Transarterial chemoembolization with anthracyclines-loaded polyethylene glycol drug eluting microspheres for the treatment of hepatocellular carcinoma: a pooled …
F Veloso Gomes, T de Baere, G Verset… - Cardiovascular and …, 2023 - Springer
Purpose To evaluate survival, efficacy and safety of transarterial chemoembolization (TACE)
in the treatment of patients with hepatocellular carcinoma (HCC), through a pooled analysis …
in the treatment of patients with hepatocellular carcinoma (HCC), through a pooled analysis …
A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma
G Fiorentini, D Sarti, R Carandina, L Mulazzani… - Future …, 2018 - Taylor & Francis
Transarterial chemoembolization (TACE) is indicated in unresectable hepatocellular
carcinoma and allows the delivery of embolics inside tumor vascularization to reduce blood …
carcinoma and allows the delivery of embolics inside tumor vascularization to reduce blood …
[HTML][HTML] Chemoembolization of hepatocellular carcinoma with drug-eluting polyethylene glycol embolic agents: single-center retrospective analysis in 302 patients
FV Gomes, JA Oliveira, MT Correia, NV Costa… - Journal of Vascular and …, 2018 - Elsevier
Purpose To evaluate the efficacy and safety of transarterial chemoembolization with
polyethylene glycol (PEG) drug-eluting embolic agents in the treatment of hepatocellular …
polyethylene glycol (PEG) drug-eluting embolic agents in the treatment of hepatocellular …
Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study
Q Du, M Liang, B Jiang, M Zhang, X Yu, X Li… - European Journal of …, 2023 - Elsevier
Purpose To assess the incidence and predictive factors of abdominal pain following
transarterial hepatic chemoembolization (TACE) in patients with hepatocellular carcinoma …
transarterial hepatic chemoembolization (TACE) in patients with hepatocellular carcinoma …